Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/53797
Title: | Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries. | Authors: | Ho P.J.;Yan Loo C.K.;Goh M.H.;Abubakar M.;Ahearn T.U.;Andrulis I.L.;Antonenkova N.N.;Aronson K.J.;Augustinsson A.;Behrens S.;Bodelon C.;Bogdanova N.V.;Bolla M.K.;Brantley K.;Brenner H.;Byers H.;Camp N.J.;Castelao J.E.;Cessna M.H.;Chang-Claude J.;Chanock S.J.;Chenevix-Trench G.;Choi J.-Y.;Colonna S.V.;Czene K.;Daly M.B.;Derouane F.;Dork T.;Eliassen A.H.;Engel C.;Eriksson M.;Evans D.G.;Fletcher O.;Fritschi L.;Gago-Dominguez M.;Genkinger J.M.;Geurts-Giele W.R.R.;Glendon G.;Hall P.;Hamann U.;Ho C.Y.S.;Ho W.-K.;Hooning M.J.;Hoppe R.;Howell A.;Humphreys K.;Investigators A.;Investigators K.;Investigators S.;Investigators M.;Ito H.;Iwasaki M.;Jakubowska A.;Jernstrom H.;John E.M.;Johnson N.;Kang D.;Kim S.-W.;Kitahara C.M.;Ko Y.-D.;Kraft P.;Kwong A.;Lambrechts D.;Larsson S.;Li S.;Lindblom A.;Linet M.;Lissowska J.;Lophatananon A.;MacInnis R.J.;Mannermaa A.;Manoukian S.;Margolin S.;Matsuo K.;Michailidou K.;Milne R.L.;Mohd Taib N.A.;Muir K.;Murphy R.A.;Newman W.G.;O'Brien K.M.;Obi N.;Olopade O.I.;Panayiotidis M.I.;Park S.K.;Park-Simon T.-W.;Patel A.V.;Peterlongo P.;Plaseska-Karanfilska D.;Pylkas K.;Rashid M.U.;Rennert G.;Rodriguez J.;Saloustros E.;Sandler D.P.;Sawyer E.J.;Scott C.G.;Shahi S.;Shu X.-O.;Shulman K.;Simard J.;Southey M.C.;Stone J.;Taylor J.A.;Teo S.-H.;Teras L.R.;Terry M.B.;Torres D.;Vachon C.M.;Van Houdt M.;Verhoeven J.;Weinberg C.R.;Wolk A.;Yamaji T.;Yip C.H.;Zheng W.;Hartman M.;Li J. | Monash Health Department(s): | Monash University - School of Clinical Sciences at Monash Health | Institution: | (Ho, Yan Loo, Goh, Investigators, Li) Human Genetics Division, Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore (Ho, Investigators, Hartman) Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore (Abubakar, Ahearn, Chanock, Kraft) Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, United States (Andrulis, Glendon) Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada (Andrulis) Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada (Antonenkova, Bogdanova) N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus (Aronson) Department of Public Health Sciences, Sinclair Cancer Research Institute, Queen's University, Kingston, ON, Canada (Augustinsson, Jernstrom) Oncology, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden (Behrens, Chang-Claude) Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Germany (Bodelon, Patel, Teras) Department of Population Science, American Cancer Society, Atlanta, GA, United States (Bogdanova) Department of Radiation Oncology, Hannover Medical School, Germany (Bogdanova, Dork, Park-Simon) Gynaecology Research Unit, Hannover Medical School, Germany (Bolla, Li, Michailidou) Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom (Brantley, Eliassen) Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States (Brenner) Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Germany (Brenner) German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Germany (Byers, Evans, Newman) Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom (Camp, Colonna) Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States (Castelao) Oncology and Genetics Unit, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Vigo, Spain (Cessna) Intermountain Healthcare, Salt Lake City, UT, United States (Chang-Claude) Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Chenevix-Trench) Cancer Research Program, QIMR Berghofer Medical Research Institute, Vol. Locked Bag 2000, Herston, QLD, Australia (Choi) Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, South Korea (Choi, Kang, Park) Cancer Research Institute, Seoul National University, Seoul, South Korea (Choi) Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, South Korea (Czene, Eriksson, Hall, Humphreys, Rodriguez) Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (Daly) Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, United States (Derouane, Van Houdt, Verhoeven) Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium (Eliassen) Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States (Eliassen) Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States (Engel) Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany (Engel) LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany (Evans, Newman) North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom (Fletcher, Johnson) The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom (Fritschi) School of Population Health, Curtin University, Perth, WA, Australia (Gago-Dominguez) Cancer Genetics and Epidemiology Group, Genomic Medicine Group, Fundacion Instituto de Investigacion Sanitaria de Santiago de Compostela (FIDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain (Genkinger, Terry) Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States (Genkinger) Herbert Irving Comprehensive Cancer Center, New York, NY, United States (Geurts-Giele, Hooning) Department of Clinical Genetics, Erasmus University Medical Center, Vol. P.O. Box 2040, 3000 CA, Rotterdam, Netherlands (Hall, Margolin) Department of Oncology, Sodersjukhuset, Stockholm, Sweden (Hamann, Rashid, Torres) Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany (Ho) Department of Molecular Pathology, Hong Kong Sanatorium and Hospital, Hong Kong (Ho) School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Semenyih, Malaysia (Ho, Investigators, Teo) Cancer Research Malaysia, Sodersjukhuset, Subang Jaya, Malaysia (Hooning) Department of Medical Oncology, Erasmus MC Cancer Institute, Vol. P.O. Box 2040, 3000 CA, the, Rotterdam, Netherlands (Hoppe) Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany (Hoppe) University of Tubingen, Tubingen, Germany (Howell) Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom (Investigators) Australian Breast Cancer Tissue Bank, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia (Investigators) Research Department, Peter MacCallum Cancer Center, Australia, Melbourne, VIC, Australia (Investigators) Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia (Investigators, Hartman) Department of Surgery, National University Health System, Singapore, Singapore (Investigators, Hartman, Li) Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore (Investigators) Cancer Genetics Service, National Cancer Centre, Singapore, Singapore (Investigators) Breast Department, KK Women's and Children's Hospital, Singapore, Singapore (Investigators) SingHealth Duke-NUS Breast Centre, Singapore, Singapore (Investigators) Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore (Investigators) Division of Surgery and Surgical Oncology, National Cancer Centre, Singapore, Singapore (Investigators) Department of General Surgery, Singapore General Hospital, Singapore, Singapore (Investigators) Division of Breast Surgery, Department of General Surgery, Changi General Hospital, Singapore, Singapore (Investigators) Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore (Investigators) Division of Medical Oncology, National Cancer Centre, Singapore, Singapore (Investigators) Breast Cancer Research Unit, University Malaya Cancer Research Institute, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (Ito) Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan (Ito, Matsuo) Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan (Iwasaki, Yamaji) Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan (Jakubowska) Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland (Jakubowska) International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland (John) Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, United States (John) Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, United States (Kang, Park) Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea (Kim) Department of Surgery, Daerim Saint Mary's Hospital, Seoul, South Korea (Kitahara, Linet) Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States (Ko) Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, Bonn, Germany (Kwong) Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong (Kwong) Department of Surgery, The University of Hong Kong, Hong Kong (Kwong) Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong (Lambrechts) Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium (Lambrechts) VIB Center for Cancer Biology, VIB, Belgium (Larsson, Wolk) Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (Larsson) Department of Surgical Sciences, Uppsala University, Uppsala, Sweden (Li, MacInnis, Milne, Stone) Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia (Li, Milne, Southey) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (Lindblom) Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden (Lindblom) Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden (Lissowska) Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Oncology Institute, Warsaw, Poland (Lophatananon, Muir) Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom (MacInnis, Milne, Southey) Cancer Epidemiology Division, Cancer Council Victoria, Australia, Melbourne, VIC, Australia (Mannermaa) Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland (Mannermaa) Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland (Mannermaa) Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland (Manoukian) Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy (Margolin) Department of Clinical Science and Education, Sodersjukhuset, Karolinska Institutet, Stockholm, Sweden (Matsuo) Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan (Michailidou) Biostatistics Unit, The Cyprus Institute of Neurology and Genetics Vol., P.O.Box 23462, Nicosia, Cyprus, Nicosia, Cyprus (Mohd Taib, Teo, Yip) Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia (Murphy, Shahi) School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada (Murphy) Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada (O'Brien, Sandler, Taylor) Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States (Obi) Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Obi) Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (Olopade) Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, United States (Panayiotidis) Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Vol. P.O.Box 23462, 1683, Cyprus, Nicosia, Cyprus (Park) Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, South Korea (Peterlongo) Genome Diagnostics Program, IFOM ETS - the AIRC Institute of Molecular Oncology, Milan, Italy (Plaseska-Karanfilska) Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', MASA, Skopje, North Macedonia (Pylkas) Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland (Pylkas) Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre, Oulu, Finland (Rashid) Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan (Rennert) Faculty of Medicine, Technion, Israel Institute of Technology and Association for Promotion of Research in Precision Medicine, Israel, Israel (Saloustros) Division of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece (Sawyer) School of Cancer & Pharmaceutical Sciences, Comprehensive Cancer Centre, Guy's Campus, King's College London, United Kingdom (Scott) Department of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, United States (Shu, Zheng) Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, United States (Shulman) Clalit Regional Oncology Unit, Haifa and Western Galilee District, Israel, Israel (Simard) Genomics Center, Centre Hospitalier Universitaire de Quebec, Universite Laval Research Center, Quebec City, QC, Canada (Southey) Department of Clinical Pathology, The University of Melbourne, Melbourne, Australia (Stone) Genetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Perth, WA, Australia (Taylor) Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States (Torres) Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia (Vachon) Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, United States (Weinberg) Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, United States (Yip) Subang Jaya Medical Centre, Selangor, Subang Jaya, Malaysia (Li) National Cancer Centre, Singapore, Singapore |
Issue Date: | 14-May-2025 | Copyright year: | 2025 | Publisher: | medRxiv | Place of publication: | United States | Publication information: | medRxiv. (no pagination), 2025. Date of Publication: 03 Mar 2025. | Journal: | medRxiv | Abstract: | Background Breast cancer is multifactorial. Focusing on limited risk factors may miss high-risk individuals. Methods We assessed the performance and overlap of various risk factors in identifying high-risk individuals for invasive breast cancer (BrCa) and ductal carcinoma in situ (DCIS) in 161,849 European-ancestry and 18,549 Asian-ancestry women. Discriminatory ability was evaluated using the area under the receiver operating characteristic curve (AUC). High-risk criteria included: 5-year absolute risk >=1.66% by the Gail model [GAILbinary]; first-degree family history of breast cancer [FHbinary]; 5-year absolute risk >=1.66% by a 313-variants polygenic risk score [PRSbinary]; and carriers of pathogenic variants in breast cancer predisposition genes [PTVbinary]. Findings The 5-year absolute risk by PRS outperformed the Gail model in predicting BrCa (Europeansvs controls: AUCPRS=0.635 [0.632-0.638] vs AUCGail=0.492 [0.489-0.495]; Asiansvs controls: AUCPRS=0.564 [0.556-0.573] vs AUCGail=0.506 [0.497-0.514]). PRSbinary and GAILbinary identified more high-risk European than Asia individuals. High-risk proportions were higher among BrCa (16-26%) and DCIS (20-33%) compared to controls (9-15%) among young Europeans and all Asians. Fewer than 7% of BrCa, 10% of DCIS, and 3% of controls were classified as high-risk by multiple risk classifiers. Overlap between PRSbinary and PTVbinary was minimal (<0.65% Europeans, <0.15% Asians) compared to the proportion at high risk using PTVbinary alone (Europeans: 4.6%, Asians: 4.4%) and PRSbinary alone (Europeans: 13.9%, Asians: 8.5%). PRSbinary and FHbinary uniquely identified 5-6% and 9-11% of young BrCa, respectively. Interpretation The incomplete overlap between high-risk individuals identified by PRSbinary, GAILbinary, FHbinary, and PTVbinary highlights the need for a comprehensive approach to breast cancer risk prediction. SIGNIFICANCE This study shows that different ways of predicting breast cancer risk do not always flag the same people, suggesting that combining multiple risk factors could improve early detection and screening.Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license. | DOI: | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1101/2025.02.27.25323002 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/53797 | Type: | Preprint | Subjects: | breast cancer | Type of Clinical Study or Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.